Avid Bioservices Inc (CDMO)

[jakedogman1]

based on a quick comparison, looks to me bavi did well relative to the patient status.. based on some quick research, the two biggest factors in HCC success of other HCC trials were ECOG status and macrovascular invasion.

here is a comparison of s and s+bavi

http://www.nejm.org/doi/pdf/10.1056/NEJMoa0708857

http://www.peregrineinc.com/images/stories/pdfs/gi_yopp_2015.pdf

ecog 0 (54%) and ecog 2 (8%) for s alone; ecog s+bavi (34%) (does anyone know how many ecog 1 vs 2 in s+bavi.. if there were more ecog 2 than ecog 1 than bavi did quite well)

macrovascular invasion (36%) in s and (84%) in s+bavi

disease control rate (43%) for s vs (58%) s+bavi